ConquerFear-HK: A Randomized Controlled Trial of a Metacognition-Based, Manualized Intervention for Fear of Cancer Recurrence among Chinese Cancer Survivors

元认知 干预(咨询) 随机对照试验 癌症 心理治疗师 心理学 医学 临床心理学 肿瘤科 内科学 精神科 认知
作者
Danielle Wing Lam Ng,Raymond T. Ng,Chunyu Guo,Julia Y. Chan,Richard Fielding,Julia Wei Chun Tang,Wylie Wai Yee Li,CC Foo,Ava Kwong,Simon S.M. Ng,Dacita Suen,Sara Fung,Oi Kwan Chun,Karen K. L. Chan,Amy Tien Yee Chang,Phyllis Butow,Wwt Lam
出处
期刊:Psychotherapy and Psychosomatics [Karger Publishers]
卷期号:: 1-17
标识
DOI:10.1159/000547888
摘要

Introduction: Fear of cancer recurrence (FCR) is a prominent clinical issue among cancer survivors. This study evaluated the effectiveness of the culturally adapted ConquerFear-HK intervention in reducing FCR among Chinese cancer survivors, compared to standard survivorship care. Methods: This assessor-masked, two-arm parallel randomized controlled trial, was conducted from June 2021 to February 2024. Cantonese- or Mandarin-speaking Chinese cancer survivors scoring ≥13 on the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) were randomized to either ConquerFear-HK, focusing on attention training, metacognition modification, acceptance, appropriate monitoring behaviour, and goal setting or active control providing standardized, multidisciplinary survivorship care. Primary outcome was changes in FCR assessed by FCRI at prior randomization, immediately post-intervention (T1), 3 months (T2), and 6 months (T3) post-intervention. Intention-to-treat analyses using linear mixed modelling compared outcome changes across time points. This trial was registered at <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov" xmlns:xlink="http://www.w3.org/1999/xlink">ClinicalTrials.gov</ext-link> (NCT04568226). Results: Of the 175/220 (79.5%) participants recruited, 89 were randomized to ConquerFear-HK and 86 to control. Significant greater FCRI reductions were observed in ConquerFear-HK at T1 (mean difference = −10.66; 95% CI:-20.15, −1.16) and T2 (mean difference = −12.00; 95% CI:-21.90, −2.11) vs. the control (g = 0.33–0.36). No significant between-group differences were found at T3. Conclusion: ConquerFear-HK demonstrates promising short-term (3-month) improvements in FCR among Chinese cancer survivors; however, no sustained benefits were found at 6 months. Possible explanations include the high attrition at 6-month follow-up, a potential early ceiling effect, unconscious therapist bias, or an accelerated adaptation effect in the intervention arm that was achieved later by the control group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
想屙shi完成签到,获得积分10
刚刚
刚刚
蛋挞发布了新的文献求助10
1秒前
毛毛发布了新的文献求助10
2秒前
石头完成签到 ,获得积分10
2秒前
course完成签到 ,获得积分10
4秒前
5秒前
核桃发布了新的文献求助10
6秒前
8秒前
9秒前
9秒前
9秒前
SciGPT应助Pinch采纳,获得10
10秒前
Faye完成签到 ,获得积分10
10秒前
彦卿完成签到 ,获得积分10
10秒前
10秒前
毛毛完成签到,获得积分10
12秒前
科研通AI6.4应助蛋挞采纳,获得10
12秒前
Zzz完成签到,获得积分10
13秒前
my123发布了新的文献求助10
14秒前
天真大神发布了新的文献求助10
14秒前
斯文败类应助尤海露采纳,获得10
14秒前
xx发布了新的文献求助30
15秒前
MOON发布了新的文献求助10
16秒前
丁鹏笑完成签到 ,获得积分0
16秒前
JackHao发布了新的文献求助10
16秒前
123完成签到 ,获得积分10
16秒前
心想事成发布了新的文献求助10
17秒前
曹苍久发布了新的文献求助10
17秒前
17秒前
17秒前
xuke完成签到 ,获得积分10
18秒前
阿巧发布了新的文献求助20
19秒前
i97完成签到 ,获得积分10
21秒前
24秒前
25秒前
嘎嘎嘎完成签到 ,获得积分10
26秒前
深情安青应助NguyenRe18采纳,获得10
27秒前
28秒前
天天快乐应助nnnnnn采纳,获得10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Introducing the Learning Sciences 600
Resiliency Scale for Adolescents--Chinese Version 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7322496
求助须知:如何正确求助?哪些是违规求助? 8937903
关于积分的说明 18949704
捐赠科研通 6980192
什么是DOI,文献DOI怎么找? 3215016
关于科研通互助平台的介绍 2382525
邀请新用户注册赠送积分活动 2194243